In silico prediction and experimental validation to reveal the protective mechanism of Puerarin against excessive extracellular matrix accumulation through inhibiting ferroptosis in diabetic nephropathy-Reference-Cited by-同舟云学术

In silico prediction and experimental validation to reveal the protective mechanism of Puerarin against excessive extracellular matrix accumulation through inhibiting ferroptosis in diabetic nephropathy

Published:2024-01 Issue: Volume:319 Page:117281
ISSN:0378-8741
Container-title:Journal of Ethnopharmacology
language:en
Short-container-title:Journal of Ethnopharmacology

Author:

Hou Biyu,Ma Peng^ORCID,Yang Xinyu,Zhao Xiaoyue,Zhang Li,Zhao Yuerong,He Ping,Zhang Li,Du Guanhua,Qiang Guifen^ORCID

Funder

Chinese Academy of Meteorological Sciences

Fundamental Research Funds for the Central Universities

CAMS Innovation Fund for Medical Sciences

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference49 articles.

1. Regulators of iron homeostasis: new players in metabolism, cell death, and disease;Bogdan;Trends Biochem. Sci.,2016

2. Iron metabolism in ferroptosis;Chen;Front. Cell Dev. Biol.,2020

3. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045;Cho;Diabetes Res. Clin. Pract.,2018

4. Ferroptosis: an iron-dependent form of nonapoptotic cell death;Dixon;Cell,2012

5. Ferroptosis enhanced diabetic renal tubular injury via HIF-1α/HO-1 pathway in db/db mice;Feng;Front. Endocrinol.,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HOXD10 attenuates renal fibrosis by inhibiting NOX4-induced ferroptosis;Cell Death & Disease;2024-06-06

2. Ferroptosis inhibitors: past, present and future;Frontiers in Pharmacology;2024-05-23

3. Puerarin—A Promising Flavonoid: Biosynthesis, Extraction Methods, Analytical Techniques, and Biological Effects;International Journal of Molecular Sciences;2024-05-10

4. Puerarin: A Potential Supplement for Diabetes and its Complications;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-03-06